Medicare Enrolled
Dr. Joseph De Orio, M.D.
Urology Physician · Long Beach, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. De Orio from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. De Orio?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. De Orio
Dr. Joseph De Orio is an urology physician in Long Beach, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. De Orio performed 5,010 Medicare services across 2,146 unique beneficiaries.
Between the years covered by Open Payments, Dr. De Orio received a total of $6,639 from 55 pharmaceutical and/or device companies across 226 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. De Orio is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 19% volume in CA
$6,639 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,010
Medicare services
Top 19% in CA for urology physician
2,146
Unique beneficiaries
$57
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~264 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
1,121 | $12 | $50 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,069 | $98 | $593 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
744 | $73 | $400 |
| Lidocaine HCl injection for IV infusion, 10 mg Administration of a 10 mg dose of lidocaine hydrochloride via intravenous infusion. |
324 | $0 | $25 |
| Injection, garamycin, gentamicin, up to 80 mg | 302 | $2 | $25 |
| Complete pelvic ultrasound An imaging test using sound waves to create pictures of the organs and structures within the pelvis. |
278 | $89 | $850 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
188 | $0 | $25 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
139 | $200 | $2,500 |
| Injection, tobramycin sulfate, up to 80 mg | 103 | $2 | $125 |
| Limited retroperitoneal ultrasound A focused ultrasound exam of the area behind the abdominal cavity to evaluate specific structures. |
84 | $36 | $850 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 84 | $129 | $450 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
65 | $50 | $2,225 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
62 | $9 | $567 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
56 | $63 | $2,565 |
| New patient office visit, complex (60-74 min) | 55 | $164 | $1,132 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
42 | $95 | $550 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
39 | $89 | $850 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
39 | $29 | $1,074 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
38 | $19 | $800 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
33 | $147 | $798 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
29 | $128 | $903 |
| Limited ultrasound of pelvis A focused ultrasound exam of the pelvic area to evaluate specific structures. This procedure provides images of the pelvis to assist in medical assessment. |
27 | $40 | $850 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
24 | $196 | $8,500 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
24 | $117 | $850 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
24 | $49 | $850 |
| Ureteral stent insertion via cystoscopy A tube is placed into the ureter using an endoscope inserted through the bladder. |
17 | $42 | $3,800 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
6.8% high complexity
47.0% medium
46.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$6,639
Total received (2018-2024)
Avg $948/year across 7 years
Top 27% in CA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
55
Companies
226
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,094 (76.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,544 (23.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,029
2023
$1,194
2022
$610
2021
$1,250
2020
$538
2019
$1,100
2018
$916
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Astellas Pharma US Inc
$355
Medtronic, Inc.
$159
Sumitomo Pharma America, Inc.
$87
ABBVIE INC.
$86
ACCORD HEALTHCARE, INC.
$86
180 Medical, Inc.
$57
Myriad Genetic Laboratories, Inc.
$54
PROGENICS PHARMACEUTICALS, INC.
$44
Teleflex LLC
$35
PFIZER INC.
$27
COLOPLAST CORP
$24
Antares Pharma, Inc.
$16
Top 3 companies account for 58.4% of 2024 payments
All-time payments by company (2018-2024) ›
Astellas Pharma US Inc
$1,627
Boston Scientific Corporation
$532
Myriad Genetic Laboratories, Inc.
$417
Medtronic USA, Inc.
$354
ACCORD HEALTHCARE, INC.
$298
180 Medical, Inc.
$263
Antares Pharma, Inc.
$204
Medtronic, Inc.
$199
PFIZER INC.
$197
Axonics, Inc.
$172
Coloplast Corp
$138
Acerus Pharmaceuticals Corporation
$131
ABBVIE INC.
$130
Blue Earth Diagnostics Limited
$130
Bayer Healthcare Pharmaceuticals Inc.
$120
Teleflex LLC
$113
Sumitomo Pharma America, Inc.
$110
Smith+Nephew, Inc.
$101
Progenics Pharmaceuticals, Inc.
$93
Allergan Inc.
$92
AbbVie Inc.
$87
TOLMAR Pharmaceuticals, Inc.
$82
Metuchen Pharmaceuticals
$75
AbbVie, Inc.
$75
Dendreon Pharmaceuticals LLC
$66
Janssen Biotech, Inc.
$66
Avadel Specialty Pharmaceuticals, LLC
$61
Ethicon US, LLC
$45
Palette Life Sciences, Inc.
$44
PROGENICS PHARMACEUTICALS, INC.
$44
BOSTON SCIENTIFIC CORPORATION
$40
ABC Home Medical Supply, Inc.
$38
Photocure Inc
$31
BioTissue Holdings, Inc.
$31
UROGEN PHARMA, INC.
$31
Amniox Medical, Inc.
$31
PROCEPT BioRobotics Corporation
$29
COLOPLAST CORP
$24
Merck Sharp & Dohme LLC
$23
Ferring Pharmaceuticals Inc.
$23
Bayer HealthCare Pharmaceuticals Inc.
$22
C. R. Bard, Inc. & Subsidiaries
$22
Accord Healthcare, Inc.
$22
Myovant Sciences Inc.
$21
Telix Pharmaceuticals
$21
AKRIMAX PHARMACEUTICALS, LLC
$21
BARD PERIPHERAL VASCULAR, INC.
$20
FUJIFILM Healthcare Americas Corporation
$20
PRN Medical Services, LLC
$18
Allergan, Inc.
$17
Hollister Incorporated
$16
CONMED Corporation
$15
Novartis Pharmaceuticals Corporation
$13
Olympus America Inc.
$12
Agiliti Surgical, Inc.
$11
Top 3 companies account for 38.8% of all-time payments
Associated products mentioned in payments ›
AFINITOR · AMS · AQUABEAM ROBOTIC SYSTEM · ARIETTA PRECISION · AirSeal · Androgel · Axonics · Axonics r-SNM System · Axumin · BOTOX · BOTOX THERAPEUTIC · CAMCEVI · CONTINENCE CARE · Cysview · ECHELON FLEX Stapler · ELIGARD · ENSEAL Product Family · Erleada · FIRMAGON · GENERAL BPH · GENERAL BPH · GENERAL FEMALE SUI · ILLUCCIX · INTERSTIM · JELMYTO · KEYTRUDA · LUPRON DEPOT · MYRBETRIQ · Myrbetriq · NEOX · NOCDURNA · Natesto · Noctiva · Nubeqa · ONLI · ORGOVYX · Olympus Cysto-Resection · Otrexup · PROLARIS · PROVENGE · PYLARIFY · Prolaris · REGENETEN Shoulder · REZUM · Rezum Generator · SELF-CATH · SOLYX · SPEEDICATH · SpeediCath · Stendra · TOVIAZ · Titan · UroLift System · XTANDI · XYOSTED · Xtandi · ZYTIGA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (77%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
331
Per 100K population
3.4
County median income
$87,760
Nearest hospital
VA LONG BEACH HEALTHCARE SYSTEM
1.2 mi
1.2 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. De Orio is a clinical cardiology specialist, with above-average Medicare volume (top 19% in CA), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. De Orio experienced with drug injection, under skin or into muscle?
Based on Medicare claims data, Dr. De Orio performed 1,121 drug injection, under skin or into muscle services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. De Orio receive payments from pharmaceutical companies?
Yes. Dr. De Orio received a total of $6,639 from 55 companies across 226 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. De Orio's costs compare to other urology physicians in Long Beach?
Dr. De Orio's average Medicare payment per service is $57. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. De Orio) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Long Beach
Browse urology physicians in Long Beach ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in CA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in CA
Which CA urology physicians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
Myriad Genetic Laboratories, Inc. Payments to Doctors
See all physicians who received payments from Myriad Genetic Laboratories, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology